MGNX
MacroGenics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website macrogenics.com
- Employees(FY) 357
- ISIN US5560991094
Performance
-70.25%
1W
-73.83%
1M
-74.74%
3M
-38.43%
6M
-54.63%
YTD
-28.44%
1Y
Profile
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3;Retifanlimab, an monoclonal antibody used for cancer therapeutics; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.
Investment Analysis Report: MGNX
Overview
In this investment analysis report, we will delve into a comprehensive analysis of MGNX, a pharmaceutical company operating in the Health Technology sector. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, capital expenditu...
Technical Analysis of MGNX 2024-05-10
Overview:
In analyzing the technical indicators for MGNX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-17 00:50
- 2024-05-16 00:59
- 2024-05-13 00:30
- 2024-05-12 19:30
MacroGenics to Participate in Upcoming Investor Conferences(Globenewswire)
- 2024-05-10 07:48
Top Premarket Decliners(MT Newswires)
- 2024-05-10 07:15
- 2024-05-10 07:14
Stifel Downgrades MacroGenics to Hold(MT Newswires)
- 2024-05-10 07:12
TD Cowen Downgrades MacroGenics to Hold From Buy(MT Newswires)
- 2024-05-10 07:12
MacroGenics Says Five Patients Died in Cancer Study(MT Newswires)
- 2024-05-10 06:01
- 2024-05-10 04:57
MacroGenics Q1 Loss Widens, Revenue Falls(MT Newswires)
- 2024-05-10 04:51
Macrogenics Stock Drops 77% After Study Deaths(Yahoo Finance)
- 2024-05-10 03:29
- 2024-05-10 03:17
- 2024-05-10 02:15
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript(Motley Fool)
- 2024-05-10 02:01
Top Midday Decliners(Yahoo Finance)
- 2024-05-09 20:35
Why Is Macrogenics (MGNX) Stock Down 69% Today?(Investorplace)
- 2024-05-09 19:30
- 2024-05-09 18:02
MacroGenics' stock crashes after 5 deaths seen in ADC trial(Fiercebiotech)
- 2024-05-09 16:10
MacroGenics: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-09 08:57
- 2024-05-09 04:01
- 2024-05-03 07:30
- 2024-05-02 19:30
- 2024-04-30 22:05
- 2024-04-26 08:00
- 2024-04-19 07:04
- 2024-04-03 16:30
- 2024-04-03 04:30
- 2024-03-14 08:18
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript(Insider Monkey)
Page 1 of 6
previousnext